Skip to content

A Progressive Resistance Training Program in Patients With Haemophilia

The Impact of Progressive Resistance Training on Quality of Life in Patients With Haemophilia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02781233
Enrollment
20
Registered
2016-05-24
Start date
2017-10-24
Completion date
2018-06-25
Last updated
2018-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemophilia

Brief summary

This study evaluates the clinical impact of a progressive resistance training program in adults patients with haemophilia

Detailed description

The training program aims improving muscular strength and endurance in the relevant muscles and joints (knee, elbow, ankle, shoulder and hip) in order to improve the quality of life in the patients.

Interventions

OTHERProgressive resistance training

Progressive resistance training program

Usual daily activities

Sponsors

Shire
CollaboratorINDUSTRY
University of Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of haemophilia A or B * willingness to exercise twice a week during the training program and to complete the pre- and post-program evaluations * approval by their hematologist to participate in the exercise program * age between 18 and 60 years * informed consent signed.

Exclusion criteria

* the inability to attend exercise sessions at least twice a week for 6 consecutive weeks * non adherence to instruction on proper exercise technique * surgical procedures performed 6 weeks prior to or during the exercise program * participation in any other form of exercise, including rehabilitation, during the study; (5) changes in medication during the study * a major bleeding episode that posed a risk or prevented exercise * History of FVIII inhibitor (titer ≥ 0.6 BU \[Bethesda unit\]) or detectable FVIII inhibitors at screening (titer ≥ 0.4 BU) * Another haemostatic defect * Need for major surgery * Withdrawal of informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Muscle strengthbaseline and 8 weeksFor measuring the isometric knee flexion and extension, ankle plantarflexion and dorsiflexion strength and isometric elbow flexion and extension strength, a portable hand-held dynamometer will be used (Nicholas Manual Muscle Tester, Lafayette Instruments, Indiana, USA).

Secondary

MeasureTime frameDescription
Change in Haemophilia Quality of life questionnaire (A36 Haemophilia-QoL® )baseline and 8 weeksThe Haemophilia-QoL questionnaire is a self-report modular instrument that assesses nine relevant HRQoL domains for patients with haemophilia (e.g. physical health, daily activities, joint damage, pain, treatment satisfaction, treatment difficulties, emotional functioning, mental health, relationships and social activity).
Change in Bleedingsdaily (during the 8 weeks of intervention)Number of Bleedings During the study
Change in viscoelastic properties (rectus femoris)baseline and 8 weeksMyoton Pro
Change in sit-to-stand testbaseline and 8 weeksThe time taken for the participant to stand up and sit down from a standard 45 cm chair with arms three times, as quickly as possible, was measured.
Change in Haemophilia Activities List questionnairebaseline and 8 weeksThe Haemophilia Activities List questionnaire measures the impact of hemophilia on self-perceived functional abilities in adults. It contains 42 multiple choice questions in seven domains: Lying/sitting/kneeling/standing (8 items) Functions of the legs (9 items) Functions of the arms (4 items) Use of transportation (3 items) Self-care (5 items) Household tasks (6 items) Leisure activities and sports (7 items) The most important outcomes are the overall sum score and three component scores relating to upper extremity activities, basic lower extremity activities, and complex lower extremity activities. A domain score for each of the seven domains can also be calculated.
Change in Timed Up and Gobaseline and 8 weeksThe Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.
Change in Painbaseline and 8 weeks11-point numerical pain rating scale with higher score meaning higher pain
Change in workability indexbaseline and 8 weeksworkability index with single question
Change in analgesics use (days/week)baseline and 8 weeksThe number of days the participants used analgesics during the last week
Change in Range Of Motion (ROM)baseline and 8 weekselbow extensio/flexion, ankle dorsiflexion/plantar flexion and knee flexion/extension ROM with a goniometer
Change in Kinesiophobiabaseline and 8 weeksTampa Scale of Kinesiophobia (TSK-11SV) used to assess changes in fear of movement
Change in The Haemophilia Joint Health Score (HJHS)baseline and 8 weeksThe HJHS measures joint health, in the domain of body structure and function (i.e. impairment), of the joints most commonly affected by bleeding in hemophilia: the knees, ankles, and elbows.The HJHS 2.1 provides a total score (higher score is worse; max=124), joint specific scores, and a global gait score.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026